Corcept Therapeutics (CORT) Total Debt (QoQ) (2012 - 2017)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -54.75% |
| Mar 31, 2017 | -31.08% |
| Dec 31, 2016 | -21.69% |
| Sep 30, 2016 | -16.04% |
| Jun 30, 2016 | -10.94% |
| Mar 31, 2016 | -8.92% |
| Dec 31, 2015 | -7.24% |
| Sep 30, 2015 | -5.70% |
| Jun 30, 2015 | -4.12% |
| Mar 31, 2015 | -3.25% |
| Dec 31, 2014 | -2.20% |
| Sep 30, 2014 | -1.09% |
| Jun 30, 2014 | -0.23% |
| Mar 31, 2014 | 0.14% |
| Dec 31, 2013 | 1.22% |
| Sep 30, 2013 | 2.23% |
| Jun 30, 2013 | 3.33% |
| Mar 31, 2013 | 3.52% |
| Dec 31, 2012 | 3.61% |